
|Articles|February 6, 2004
New fillers expanding patients' options
With a handful of new options expected to receive FDA approval withina year, the field of tissue augmentation stands poised to undergo a seismicshift. "The bottom line is, tissue augmentation is about to changedramatically," said Mariano E. Busso, M.D. He is clinical professorin the University of Miami's department of dermatology, chief of dermatologyat Mercy Hospital, also in Miami, Fla., and a private practitioner who isboard-certified in dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















